Literature DB >> 21184636

Correlation of matrix metalloproteinases-1 and -3 with patient age and grade of lumbar disc herniation.

Andreas Zigouris1, Anna Batistatou, George A Alexiou, Dimitrios Pachatouridis, Evaggelos Mihos, Dimitrios Drosos, George Fotakopoulos, Michail Doukas, Spyridon Voulgaris, Athanasios P Kyritsis.   

Abstract

OBJECT: The authors studied the histological alterations and the expression of matrix metalloproteinase (MMP)-1 and MMP-3 in disc specimens of patients who had undergone operations for lumbar disc herniation.
METHODS: Forty-three lumbar disc specimens were evaluated histopathologically for degenerative changes and immunohistochemical expression of MMP-1 and MMP-3. The observed degenerative changes provided a degenerative score that was applied in each patient. Sections of disc immunostained for MMP-1 and MMP-3 were evaluated semiquantitatively. Patients were categorized in 3 age groups: < 30 years, between 30 and 60 years, and > 60 years of age. The expression of MMP-1 and MMP-3 were correlated to patient's age, degenerative score, and grade of lumbar disc herniation.
RESULTS: There was no statistically significant difference in the degenerative score between the age groups. Degenerative changes were more pronounced in greater grades of herniation (p < 0.0001). In the group of patients < 30 years of age there was a significant correlation between MMP-1 and MMP-3 expression and both degenerative score and herniation grade. For the group of patients 30-60 years of age, there was no significant difference between MMP-1 expression and degenerative score, but the correlation between MMP-1 expression and grade of herniation was significant. There was a significant correlation between MMP-3 expression and both degenerative score and herniation grade. Regarding the patients > 60 years of age, there was a significant correlation between MMP-1 and MMP-3 expression and both degenerative score and herniation grade. There was a significantly lower expression of both MMP-1 and MMP-3 in the group < 30 years of age compared with the other ages. No significant correlation was found in MMP-1 and MMP-3 expression between the groups of patients who were 30-60 and > 60 years of age. Interestingly, in age groups > 30 years, there were no statistically significant differences between the expression of MMP-1 and MMP-3, whereas in patients < 30 years of age the expression of MMP-3 was significantly lower than the expression of MMP-1.
CONCLUSIONS: The expression of MMP-1 and MMP-3 were strongly correlated to the age of the patients and the grade of herniation. An important finding in this study is the differential expression of MMP-1 and MMP-3 between the age groups. In the young age group it appears that deregulation of MMP-1 expression is higher than that of MMP-3 in the pathogenesis of lumbar disc herniation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21184636     DOI: 10.3171/2010.9.SPINE09935

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  14 in total

1.  Relationship between neovascularization and degenerative changes in herniated lumbar intervertebral discs.

Authors:  Tõnu Rätsep; Ave Minajeva; Toomas Asser
Journal:  Eur Spine J       Date:  2013-06-05       Impact factor: 3.134

2.  MicroRNA-93 regulates collagen loss by targeting MMP3 in human nucleus pulposus cells.

Authors:  Wanli Jing; Wenxue Jiang
Journal:  Cell Prolif       Date:  2015-03-27       Impact factor: 6.831

3.  Developments in intervertebral disc disease research: pathophysiology, mechanobiology, and therapeutics.

Authors:  Kathryn T Weber; Timothy D Jacobsen; Robert Maidhof; Justin Virojanapa; Chris Overby; Ona Bloom; Shaheda Quraishi; Mitchell Levine; Nadeen O Chahine
Journal:  Curr Rev Musculoskelet Med       Date:  2015-03

4.  Investigation of the relationship between chromobox homolog 8 and nucleus pulposus cells degeneration in rat intervertebral disc.

Authors:  Xu Zhou; Hai-Long Zhang; Guang-Fei Gu; Yue Ding; Jian-Bo Jia; Qing-Song Fu; Shi-Sheng He
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-04-10       Impact factor: 2.416

5.  Osthole, a herbal compound, alleviates nucleus pulposus-evoked nociceptive responses through the suppression of overexpression of acid-sensing ion channel 3 (ASIC3) in rat dorsal root ganglion.

Authors:  Qiu-Lan He; Yuling Chen; Jian Qin; Sui-Lin Mo; Ming Wei; Jin-Jun Zhang; Mei-Na Li; Xue-Nong Zou; Shu-Feng Zhou; Xiao-Wu Chen; Lai-Bao Sun
Journal:  Med Sci Monit       Date:  2012-06

6.  Expression and Mechanism of Interleukin 1 (IL-1), Interleukin 2 (IL-2), Interleukin 8 (IL-8), BMP, Fibroblast Growth Factor 1 (FGF1), and Insulin-Like Growth Factor (IGF-1) in Lumbar Disc Herniation.

Authors:  Zhengkuan Xu; Xiaopeng Zhou; Gang Chen
Journal:  Med Sci Monit       Date:  2019-02-04

7.  Galectins-1 and -3 in Human Intervertebral Disc Degeneration: Non-Uniform Distribution Profiles and Activation of Disease Markers Involving NF-κB by Galectin-1.

Authors:  Mahmoud Elshamly; Katharina Kinslechner; Josef G Grohs; Daniela Weinmann; Sonja M Walzer; Reinhard Windhager; Hans-Joachim Gabius; Stefan Toegel
Journal:  J Orthop Res       Date:  2019-06-24       Impact factor: 3.494

8.  Association of endothelin-1 expression and cartilaginous endplate degeneration in humans.

Authors:  Wei Yuan; Ming-Dong Zhao; Feng-Lai Yuan; Wu Che; Ping-Guo Duan; Yi Liu; Jian Dong
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

9.  Trend of the incidence of lumbar disc herniation: decreasing with aging in the elderly.

Authors:  Daoyou Ma; Yunbiao Liang; Daoming Wang; Zejiang Liu; Wei Zhang; Tantan Ma; Liang Zhang; Xingjun Lu; Zhiyou Cai
Journal:  Clin Interv Aging       Date:  2013-08-07       Impact factor: 4.458

10.  Differences in the Incidence of Symptomatic Cervical and Lumbar Disc Herniation According to Age, Sex and National Health Insurance Eligibility: A Pilot Study on the Disease's Association with Work.

Authors:  Young-Ki Kim; Dongmug Kang; Ilho Lee; Se-Yeong Kim
Journal:  Int J Environ Res Public Health       Date:  2018-09-25       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.